NCT04030429 2025-07-16
Crizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial Cancer
National Cheng-Kung University Hospital
Phase 2 Terminated
Clinical Trials
4 trialsNCT02612194 2022-11-03
LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer
Wake Forest University Health Sciences
Phase 2 Terminated
NCT01548144 2021-09-13
Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT02074878 2017-08-09
CRIZENT
Baylor Breast Care Center
Phase 1 Terminated